The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...

Those who knew Brian Thompson, CEO of UnitedHealthcare, struggled to process the news that he had been shot and killed in New ...

Conservative Supreme Court justices appeared skeptical Wednesday of arguments that they should intervene in Tennessee’s ban ...

Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

"There was hard industry pushback against the rule,” said Sean Tu, a West Virginia University law professor who studies ...

The Supreme Court decision on Tennessee’s ban will have implications not just for trans people, but for state regulation of ...

Negotiations over a large health care policy package are heating up as Congress hurtles toward a government funding deadline ...

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...

Eli Lilly said its drug Zepbound led to greater weight reduction than rival Novo Nordisk's Wegovy in a head-to-head ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

UnitedHealth Group executives were in New York City on Wednesday for their annual investor conference, which was abruptly canceled.

Good morning! Another health care case comes to the Supreme Court today. See my preview below, and keep an eye out for more coverage later today. STAT's ...